Infusion site irritation
(UMLS:C1695897)
- UMLS ID:
- C1695897
- MeSH ID:
- N/A
Synonym(s)
1.
Infusion site irritation
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Bendamustine Hydrochloride | FAERS: 31 | US FAERS | |
| 2 | treprostinil | FAERS: 22 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 3 | Aprepitant | FAERS: 8 | US FAERS | |
| 4 | insulin aspart, insulin aspart protamine drug combination 30:70 | FAERS: 7 | US FAERS | |
| 5 | Dantrolene | FAERS: 6 | US FAERS | |
| 6 | Moxifloxacin | FAERS: 6 | US FAERS | |
| 7 | Ciprofloxacin | FAERS: 4 | US FAERS | |
| 8 | Penicillin G | FAERS: 3 | US FAERS | |
| 9 | Acetylcysteine | FAERS: 2 | OFFSIDES US FAERS | |
| 10 | Trabectedin | FAERS: 2 | US FAERS | |
| 11 | carfilzomib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Dexmedetomidine | FAERS: 1 | US FAERS | |
| 13 | Dexrazoxane | FAERS: 1 | US FAERS | |
| 14 | Ferric Oxide, Saccharated | FAERS: 1 | US FAERS | |
| 15 | Hydromorphone | FAERS: 1 | US FAERS | |
| 16 | Hydromorphone | FAERS: 1 | US FAERS | |
| 17 | Ibuprofen | FAERS: 1 | US FAERS | |
| 18 | Levofloxacin | FAERS: 1 | US FAERS | |
| 19 | Ondansetron | FAERS: 1 | US FAERS | |
| 20 | conivaptan | FAERS: 1 | US FAERS | |
| 21 | dalbavancin | FAERS: 1 | US FAERS | |
| 22 | fosaprepitant | FAERS: 1 | US FAERS | |
| 23 | gemcitabine | FAERS: 1 | US FAERS | |
| 24 | gemcitabine | FAERS: 1 | US FAERS | |
| 25 | regadenoson | FAERS: 1 | US FAERS | |
| 26 | Caspofungin | SIDER | ||
| 27 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 28 | Galactose | OFFSIDES | ||
| 29 | Methocarbamol | OFFSIDES | ||
| 30 | Sulfate | OFFSIDES | ||
| 31 | Tigecycline | OFFSIDES | ||
| 32 | Timolol | OFFSIDES | ||
| 33 | vernakalant | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.